Shares of Bristol Myers Squibb Co. rallied 3.59% to $54.29 Monday, on what proved to be an all-around grim trading session ...

Bank of America upgrades Bristol Myers to Buy, lifting its price target to $61 on pipeline catalysts, valuation support, and ...

What Happened? Shares of biopharmaceutical company Bristol Myers Squibb (NYSE:BMY) jumped 3.7% in the afternoon session after ...

If you are wondering whether Bristol-Myers Squibb is quietly becoming a value opportunity or just a classic value trap, you ...

Futures are trading higher on Monday as we head into the final trading weeks of 2025. All of the major indices were hit hard ...

Detailed price information for Bristol-Myers Squibb Company (BMY-N) from The Globe and Mail including charting and trades.

Bristol Myers’ stock rallied Wednesday as investors maintained high hopes for Cobenfy as an Alzheimer’s treatment, even ...

A U.S. judge rejected Bristol Myers Squibb's bid to dismiss a lawsuit claiming it cheated shareholders of the former Celgene ...

Data from the "ADEPT-2" study, which analysts had hoped would arrive before year's end, are now expected sometime in 2026.

The futures are trading mixed as we get set to close out a wild and woolly week that saw a touch of just about everything.

Global interim Phase 2 data in locally advanced/metastatic triple-negative breast cancer (”TNBC”) show encouraging antitumor activity for ...

BioNTech and Bristol Myers Squibb share positive data from Phase 2 trial of pumitamig plus chemotherapy for triple-negative ...